IBX utilizes cutting edge microarray and Next-Generation Sequencing platforms to achieve genome-wide detection of epigenetic events.
- Affymetrix GeneChip® and GeneTitan® Systems for all Affymetrix Genotyping products
- Illumina MiSeq, NextSeq 500, and NovaSeq 6000 platforms allow for massively parallel sequencing to meet project demands of all sizes
Bisulfite Treatment (QPCR)
Treatment of DNA with bisulfite converts cytosine residues to uracil, but leaves 5-methylcytosine residues unchanged. The methylation status of treated DNA is then determined by methylation-specific PCR (MSP) or direct sequencing.
Illumina Infinium methylation arrays are used to interrogate methylation sites at single nucleotide resolution. Medium-throughput solutions interrogate >25,000 CpG loci covering 14,000 genes, while high-throughput options cover more than 450,000 expertly selected methylation sites.
Affymetrix GeneChip Tiling arrays offer a comprehensive solution for novel isoform discovery as well as mapping the sites of protein-DNA interactions in ChIP experiments.
Rapidly survey the binding sites of transcription factors and other chromatin-associated binding proteins that influence gene regulation. Chromatin immunoprecipitated DNA is readily converted into sequencing libraries and sequenced on the Illumina MiSeq Personal Sequencers and NovaSeq 6000 platforms.
Rapidly and economically detect genome-wide methylation patterns by direct sequencing on the Illumina MiSeq Personal Sequencers and NovaSeq 6000 platforms. A variety of methods exist, including sequencing of bisulfite-converted DNA, methylation-sensitive restriction digest-enriched fragments, or chromatin immunoprecipitates of methyltransferases bound to DNA.